Your browser doesn't support javascript.
loading
Occult Hepatitis B Infection among Hemodialysis in Tabriz, Northwest of Iran: Prevalence and Mutations within the S Region.
Eslami, Narges; Poortahmasebi, Vahdat; Sadeghi, Javid; Ghotaslou, Reza; Niknafs, Bahram; Bannazadeh Baghi, Hossein; Ahangar Oskouee, Mahin.
Afiliação
  • Eslami N; Department of Microbiology and Virology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Poortahmasebi V; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Sadeghi J; Department of Microbiology and Virology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ghotaslou R; Department of Microbiology and Virology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Niknafs B; Department of Microbiology and Virology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Bannazadeh Baghi H; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ahangar Oskouee M; Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Can J Infect Dis Med Microbiol ; 2022: 3838857, 2022.
Article em En | MEDLINE | ID: mdl-35800327
Regardless of the extensive screening for the detection of hepatitis B surface antigen (HBsAg), hemodialysis (HD) patients are still severely at the risk of occult hepatitis B virus infection (OBI), especially in developing countries. OBI is defined as the presence of HBV DNA with undetectable HBsAg in the liver and/or Serum. This study aims to determine the prevalence of OBI in HD patients in Tabriz Province, northwest of Iran, and inquire about the mutations in the detected HBsAg. In this cross-sectional descriptive study, ELISA method assessed serum and plasma samples of 118 HBsAg-negative patients undergoing HD treatment for HBV serological markers (HBsAg and Anti-HBc). Specific primers by nested polymerase chain reaction have been utilized to examine HBV DNA; also, direct sequencing of surface genes was carried out to characterize the viral genotypes and S gene mutations. Finally, followed by real-time PCR, the quantity of viral load in OBI-positive patients was determined. A total of 118 HD patients were included (63.6% were male and 36.4% female), with an overall mean age of 60.8 ± 12.8 years old. The prevalence of antihepatitis B core antibody (Anti-HBc) in the study population was 26.3% (31/118). Five patients (4.2%) were positive for HBV DNA and labeled OBI-positive; their plasma HBV-DNA load was less than 100 IU/ml. Following the phylogenetic analysis, the samples with OBI roughly belonged to genotype D, subtype ayw2 and only two had mutations within the S 'gene's major hydrophilic region (MHR), including T123I, C124F, and P127T. This study reports the prevalence of OBI in the HBsAg-negative HD patients being at a rate of 4.2%, which can be a clinically vital consideration in this region. HBV serologic screening approaches need to be renewed to cover nucleic acid testing in the setting of hemodialysis and all the other high-risk groups associated with it (i.e., blood and organ donors).

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Can J Infect Dis Med Microbiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Can J Infect Dis Med Microbiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã